MetLife Investment Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Sell |
27,072
-13,784
| -34% | -$140K | ﹤0.01% | 2009 |
|
|
2025
Q1 | $228K | Sell |
40,856
-752
| -2% | -$4.2K | ﹤0.01% | 2128 |
|
|
2024
Q4 | $336K | Buy |
41,608
+5,530
| +15% | +$44.6K | ﹤0.01% | 2008 |
|
|
2024
Q3 | $370K | Hold |
36,078
| – | – | ﹤0.01% | 1950 |
|
|
2024
Q2 | $255K | Buy |
36,078
+15,341
| +74% | +$108K | ﹤0.01% | 2096 |
|
|
2024
Q1 | $285K | Hold |
20,737
| – | – | ﹤0.01% | 1983 |
|
|
2023
Q4 | $191K | Hold |
20,737
| – | – | ﹤0.01% | 2271 |
|
|
2023
Q3 | $125K | Hold |
20,737
| – | – | ﹤0.01% | 2468 |
|
|
2023
Q2 | $161K | Buy |
+20,737
| New | +$161K | ﹤0.01% | 2402 |
|
|
2022
Q1 | – | Sell |
-11,317
| Closed | -$166K | – | 2757 |
|
|
2021
Q4 | $166K | Hold |
11,317
| – | – | ﹤0.01% | 2171 |
|
|
2021
Q3 | $237K | Buy |
11,317
+1,866
| +20% | +$39K | ﹤0.01% | 1985 |
|
|
2021
Q2 | $167K | Hold |
9,451
| – | – | ﹤0.01% | 2262 |
|
|
2021
Q1 | $232K | Hold |
9,451
| – | – | ﹤0.01% | 1974 |
|
|
2020
Q4 | $320K | Buy |
+9,451
| New | +$320K | ﹤0.01% | 1727 |
|
|
2020
Q3 | – | Sell |
-4,615
| Closed | -$156K | – | 2326 |
|
|
2020
Q2 | $156K | Buy |
+4,615
| New | +$156K | ﹤0.01% | 2039 |
|